Bouwense Stefan A W, de Vries Marjan, Schreuder Luuk T W, Olesen Søren S, Frøkjær Jens B, Drewes Asbjørn M, van Goor Harry, Wilder-Smith Oliver H G
Stefan AW Bouwense, Marjan de Vries, Luuk TW Schreuder, Harry van Goor, Pain and Nociception Neuroscience Research Group, Department of Surgery, Radboud University Medical Center, 6500HB Gelderland, The Netherlands.
World J Gastroenterol. 2015 Jan 7;21(1):47-59. doi: 10.3748/wjg.v21.i1.47.
Pain in chronic pancreatitis (CP) shows similarities with other visceral pain syndromes (i.e., inflammatory bowel disease and esophagitis), which should thus be managed in a similar fashion. Typical causes of CP pain include increased intrapancreatic pressure, pancreatic inflammation and pancreatic/extrapancreatic complications. Unfortunately, CP pain continues to be a major clinical challenge. It is recognized that ongoing pain may induce altered central pain processing, e.g., central sensitization or pro-nociceptive pain modulation. When this is present conventional pain treatment targeting the nociceptive focus, e.g., opioid analgesia or surgical/endoscopic intervention, often fails even if technically successful. If central nervous system pain processing is altered, specific treatment targeting these changes should be instituted (e.g., gabapentinoids, ketamine or tricyclic antidepressants). Suitable tools are now available to make altered central processing visible, including quantitative sensory testing, electroencephalograpy and (functional) magnetic resonance imaging. These techniques are potentially clinically useful diagnostic tools to analyze central pain processing and thus define optimum management approaches for pain in CP and other visceral pain syndromes. The present review proposes a systematic mechanism-orientated approach to pain management in CP based on a holistic view of the mechanisms involved. Future research should address the circumstances under which central nervous system pain processing changes in CP, and how this is influenced by ongoing nociceptive input and therapies. Thus we hope to predict which patients are at risk for developing chronic pain or not responding to therapy, leading to improved treatment of chronic pain in CP and other visceral pain disorders.
慢性胰腺炎(CP)中的疼痛与其他内脏疼痛综合征(如炎症性肠病和食管炎)有相似之处,因此应以类似方式进行处理。CP疼痛的典型原因包括胰内压升高、胰腺炎症以及胰腺/胰腺外并发症。不幸的是,CP疼痛仍然是一个主要的临床挑战。人们认识到,持续的疼痛可能会导致中枢性疼痛处理改变,例如中枢敏化或伤害感受性疼痛调制。当出现这种情况时,针对伤害性刺激焦点的传统疼痛治疗,如阿片类镇痛或手术/内镜干预,即使在技术上成功也常常失败。如果中枢神经系统疼痛处理发生改变,应采取针对这些变化的特定治疗措施(如加巴喷丁类药物、氯胺酮或三环类抗抑郁药)。现在有合适的工具可使改变的中枢处理过程显现出来,包括定量感觉测试、脑电图和(功能)磁共振成像。这些技术可能是临床上有用的诊断工具,用于分析中枢性疼痛处理,从而确定CP及其他内脏疼痛综合征疼痛的最佳管理方法。本综述基于对相关机制的整体观点,提出了一种系统的、以机制为导向的CP疼痛管理方法。未来的研究应探讨CP中枢神经系统疼痛处理在何种情况下发生变化,以及这如何受到持续伤害性输入和治疗的影响。因此,我们希望预测哪些患者有发生慢性疼痛或对治疗无反应的风险,从而改善CP及其他内脏疼痛疾病中慢性疼痛的治疗。